Biotech

All Articles

Galapagos pauses CAR-T tissue treatment trial over Parkinsonism instance

.Galapagos has actually paused enrollment in a test of a BCMA-directed CAR-T cell therapy, pushing t...

James Wilson leaving behind Penn to introduce pair of brand new biotechs

.After greater than 30 years, gene treatment pioneer James Wilson M.D., Ph.D., is actually leaving b...

3 biotechs make an effort to trump the summer season warm by shedding staff

.As biotechs try to transform a new webpage in August, a minimum of 3 companies have actually lost p...

venBio lifts $528M for fifth lifestyle sciences VC fund

.Professional financial backing agency venBio has lifted another half a billion bucks to buy biotech...

Otsuka pays out $800M for Jnana and its own clinical-stage PKU medicine

.Otsuka Drug has gotten Boston-based Jnana Rehabs for $800 million so the Eastern biotech can get it...

FibroGen lays off 75% of US team as asset flunks 2 more tests

.FibroGen is actually drastically restructuring its business, laying off 75% of its united state sta...

Tracon relax full weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has chosen to wind down operations full weeks after an injectable immune gat...

Ideaya bags option on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on fallen short epilepsy medicine, proclaims FDA manage

.Our experts presently recognize that Takeda is planning to discover a road to the FDA for epilepsy ...

VBI Vaccines apply for bankruptcy, looks for property sale

.Immunology biotech VBI Vaccinations is actually veering precariously near the point of no return, a...